Category Archives: "News"

In memoriam: Elaine Whitaker
Elaine Whitaker died unexpectedly and peacefully on March 31, 2020. Dr. Whitaker was born in Oklahoma City, OK, and grew up in Little Rock, [...]
Coronavirus and multiple sclerosis reporting database announced by CMSC & NMSS
(Hackensack, NJ, April 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) and the National Multiple Sclerosis Society have [...]
Coronavirus and multiple sclerosis reporting database
COViMS (COVID-19 Infections in MS & Related Diseases) is a joint effort of the Consortium of MS Centers (CMSC) and the National MS [...]
Avonex and Plegridy label updates
The Plegridy (peginterferon beta-1a) Prescribing Information and the Avonex (interferon beta-1a) Prescribing Information was updated in the [...]
CMSC Annual Meeting, May 27-30, 2020 in Orlando, FL announces cancellation
(Hackensack, NJ, March 2020) --The Consortium of Multiple Sclerosis Centers (CMSC) Annual Meeting scheduled for May 27-30, 2020 in [...]
FDA approves Zeposia (Ozanimod), oral therapy for all with relapsing multiple sclerosis
The U.S. Food and Drug Administration (FDA) has approved Zeposia (ozanimod) oral capsules to treat adults with relapsing forms [...]
MedDay report top-line data from trial “SPI2” for treatment of progressive forms of multiple sclerosis
Paris, France, March 10, 2020 – MedDay Pharmaceuticals announced today that the second pivotal Phase III trial (SPI2) of its [...]
CMSC update on COVID-19: NMSS National Medical Advisory Committee recommendations
The Centers for Disease Control and Prevention (CDC) are following the outbreak of coronavirus (COVID-19), which causes a respiratory [...]
Multiple sclerosis and COVID-19 registry
Dear Colleagues and Clients:  We know you are interested in what happens to people with MS and related diseases who develop [...]
CMSC update on the Annual Meeting and COVID-19
As part of our commitment to ensuring healthy lives and promote well-being, we are providing you a list of resources related to coronavirus [...]

CMSC provides leadership in clinical research and education; develops vehicles to share information and knowledge among members; disseminates information to the health care community and to persons affected by MS.

Contact Us
Contact Us
I have a question about
First
Last

Feel Free To contact Us
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam molestie, tellus id pellen tesque feugiat, sem sem cursus orci, a placerat ante ante nec massa. consectetuer adipiscing elit.

+1-222-333-4444

New York, NY 10123 USA

Mon - Sat 9:00 AM